AG2R LA Mondiale Gestion D Actifs Takes $1.08 Million Position in Mettler-Toledo International, Inc. $MTD

Key Points

• AG2R LA Mondiale Gestion D Actifs has made a new investment in Mettler-Toledo International, Inc., acquiring 938 shares valued at approximately $1,084,000.
• Mettler-Toledo's latest quarterly earnings showed an EPS of $10.09, surpassing expectations and reflecting a 3.9% increase in revenue year-over-year.
• Various hedge funds have adjusted their positions in Mettler-Toledo, with a combined institutional ownership now at 95.07% of the company’s stock.

AG2R LA Mondiale Gestion D Actifs acquired a new stake in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 938 shares of the medical instruments supplier's stock, valued at approximately $1,084,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Vanguard Group Inc. raised its stake in Mettler-Toledo International by 1.2% in the first quarter. Vanguard Group Inc. now owns 2,543,365 shares of the medical instruments supplier's stock valued at $3,003,485,000 after buying an additional 30,535 shares during the period. Alliancebernstein L.P. grew its position in Mettler-Toledo International by 21.6% during the first quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier's stock worth $837,653,000 after buying an additional 126,147 shares in the last quarter. Price T Rowe Associates Inc. MD grew its position in Mettler-Toledo International by 5.5% during the first quarter. Price T Rowe Associates Inc. MD now owns 481,011 shares of the medical instruments supplier's stock worth $568,032,000 after buying an additional 25,272 shares in the last quarter. T. Rowe Price Investment Management Inc. grew its position in Mettler-Toledo International by 11.9% during the first quarter. T. Rowe Price Investment Management Inc. now owns 406,189 shares of the medical instruments supplier's stock worth $479,673,000 after buying an additional 43,082 shares in the last quarter. Finally, GAMMA Investing LLC grew its position in Mettler-Toledo International by 131,246.3% during the first quarter. GAMMA Investing LLC now owns 386,158 shares of the medical instruments supplier's stock worth $456,018,000 after buying an additional 385,864 shares in the last quarter. Institutional investors own 95.07% of the company's stock.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, Director Thomas P. Salice sold 1,062 shares of the business's stock in a transaction on Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the sale, the director owned 283 shares of the company's stock, valued at $368,154.70. The trade was a 78.96% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Gerry Keller sold 165 shares of the company's stock in a transaction on Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the completion of the transaction, the insider directly owned 94 shares in the company, valued at approximately $123,012.16. The trade was a 63.71% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 1,827 shares of company stock valued at $2,371,208 in the last 90 days. 0.77% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of equities research analysts have weighed in on MTD shares. Bank of America raised their target price on Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the company a "neutral" rating in a report on Thursday, June 26th. Barclays started coverage on Mettler-Toledo International in a research report on Tuesday, June 24th. They issued an "overweight" rating and a $1,325.00 price objective for the company. UBS Group upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and reduced their target price for the company from $1,530.00 to $1,350.00 in a research note on Tuesday, May 20th. Citigroup lifted their price target on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a "buy" rating in a research note on Thursday, August 21st. Finally, Robert W. Baird lifted their price target on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a "neutral" rating in a research note on Monday, August 4th. Five research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company's stock. According to MarketBeat, Mettler-Toledo International has a consensus rating of "Moderate Buy" and a consensus target price of $1,311.11.

Mettler-Toledo International Trading Up 1.3%

Shares of NYSE:MTD traded up $16.66 during mid-day trading on Tuesday, reaching $1,276.79. The company had a trading volume of 124,222 shares, compared to its average volume of 117,195. The firm has a market cap of $26.30 billion, a price-to-earnings ratio of 32.33, a PEG ratio of 3.78 and a beta of 1.37. The company's 50-day moving average price is $1,261.83 and its 200-day moving average price is $1,185.40. Mettler-Toledo International, Inc. has a one year low of $946.69 and a one year high of $1,521.01.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 EPS for the quarter, topping analysts' consensus estimates of $9.58 by $0.51. The company had revenue of $983.22 million for the quarter, compared to analysts' expectations of $957.41 million. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. Mettler-Toledo International's revenue was up 3.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $9.65 EPS. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, research analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.